Aquatic Capital Management LLC Keros Therapeutics, Inc. Transaction History
Aquatic Capital Management LLC
- $2.69 Billion
- Q2 2024
A detailed history of Aquatic Capital Management LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Aquatic Capital Management LLC holds 1,200 shares of KROS stock, worth $75,684. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,200Holding current value
$75,684% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding KROS
# of Institutions
168Shares Held
27.5MCall Options Held
42.8KPut Options Held
1.8K-
Black Rock Inc. New York, NY2.51MShares$159 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY1.9MShares$120 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.86MShares$117 Million0.0% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.53MShares$96.2 Million8.43% of portfolio
-
Orbimed Advisors LLC San Diego, CA1.27MShares$80 Million1.4% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $1.62B
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...